The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Feb 2019 17:15

RNS Number : 3354R
Craven House Capital PLC
27 February 2019
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Craven House Capital Plc

("Craven House" or the "Company")

 

Unaudited Interim Report for the period ended 30 November 2018

 

 

 

INVESTMENT MANAGER'S REPORT FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

For the unaudited six months to 30 November 2018, Craven House Capital ended the period with a Net Asset Value of $21,426,000 which equates to $8.57 per share. This represents a decrease of $3,439,000 from the NAV reported at the year ending May 2018. This change was largely the result of mark-to-market prices of liquid securities we intend to hold for an extended period of time. During the period the company acquired a significant asset in the shares of IIU, Inc. This acquisition marks our first significant presence in the United States. As mentioned in previous communications we see the US as an attractive investment destination given the global investment markets and the current stage of the debt and business cycles. We remain concerned about asset values in emerging markets and Europe and have a current preference for smaller private and listed enterprises in North America. It remains a difficult environment for value investors, however, we have recently identified what we believe are pockets of opportunity. 

 

Portfolio Update

The summary of the valuations of Craven's investment holdings as at the period end is as follows;

Investment

Value at 30 Nov

2018

Value at 31 May 2018

 

 

 

Shares in Craven Industrial Holdings Plc

$23,892,006

$26,993,468

 

 

 

Comprising:

 

 

 

Shares in DLC Holdings Corp.

$6,491,893

$11,083,190

Shares in Qeton Ltd

$1,551,814

$1,787,286

Shares in Craven House Angola LDA

$8,903,150

$8,733,274

Shares in Craven House Capital North America LLC

$4,528,396

$2,677,994

Shares in Kwikbuild Corporation Ltd

$2,416,753

$2,711,724

 

DLC Holdings Corp. (TSX:DLC)

DLC Holdings Corp. is a primary investment subsidiary focused on agricultural related investments in Brazil and South Africa. As a micro-cap listed company, its share price can fluctuate significantly without any change to the intrinsic value of the company. Despite the shares trading recently at CAD $0.25 per share on significant volume, the shares closed the period at CAD $0.15 resulting in an accounting valuation significantly lower than the prior period. We remain highly confident in the long term value of DLC's current portfolio and in the listed platform providing a platform to consolidate other assets.

Craven House Angola LDA.

Craven House Angola is primarily engaged in the provision of working capital, as previously announced, to successful European and US entrepreneurs operating in Angola for many years. Oil revenues comprise the vast majority of Angola's foreign currency earnings and a multi-year weakness in the oil price has created a scarcity of foreign currency within the banking system. As a result, good companies have had to seek funding beyond the traditional banks to finance imports. We are fortunate to have good partners in Angola who have managed the difficult operating environment profitably. The recent peaceful transition of political power combined with higher oil prices have increased the likelihood of an economic recovery. While we believe this does not present a threat to our capital it is a threat to continued profitability and margins. Should capital controls be reduced or lifted our funds will no longer be needed by our partners. If this were to happen we would need to find an alternative opportunity to deploy capital or seek to expatriate funds. It is important to note that our investment success in Angola is primarily the result of an economic anomaly created by exogenous forces rather than business acumen or operational expertise.

 

INVESTMENT MANAGER'S REPORT FOR THE SIX MONTH PERIOD ENDED

30 NOVEMBER 2018

 

 

Qeton Ltd

 

Qeton is a trading company which specialises in the purchase of globally sourced products for importation into capital constrained economies. At present the focus is on consumer goods and industrial products into Angola where capital controls continue to add significant friction to funds flow and trade. Our relationship with on the ground operators in the region provide insights into the shifting market dynamics. The current economic and political situation remains positive for Qeton, however, this could change at any moment if the Kwanza becomes more freely convertible or capital controls are lifted entirely. Should this happen we would seek to repatriate capital from Angola for investment elsewhere.

 

Craven House Capital North America LLC

 

As mentioned above, the United States is becoming an investment focus for Craven House. Our holding in IIU, Inc. has been rewarding as is demonstrated by the transaction announced on January 17, 2019 with LM Funding America, Inc. Additionally, we are finding investment opportunities in small-cap and micro-cap listed securities traded on the NYSE and NASDAQ. These companies have largely been abandoned by investors as market dynamics have moved towards passive index funds and other structured products. Additionally, many US brokerages restrict shareholders buying shares trading at less than $5 or with a market capitalisation of under $50 million. We believe this presents significant opportunities as many of these very small listed companies are trading at a discount to their orderly liquidation value and/or intrinsic value. 

 

Kwikbuild Corp.

 

As mentioned in previous communication we are bearish on South Africa given the political and economic climate. Our portfolio in South Africa is in the process of being liquidated and we intend to allocate the capital elsewhere. Fortunately, the bulk of our portfolio consists of debt secured by assets and the proceeds can be freely repatriated through the banking system unless further currency controls are enacted. This is not an insignificant risk given the state of the South African economy.

 

 

 Reduction in Capital

We continue to move forward with the legal process to buy back Craven House shares for cancellation. However, given the current share price combined with the expected liquidity over then next year, we expect share buybacks to be a central aspect of our capital allocation process until such time as the share price closes the gap with the intrinsic value of the company. Craven House has consistently issued shares at a premium and will endeavour to buy back as many shares as are available at a discount. As highlighted in the May 2018 year-end accounts, the Board will continue to assess the value of the AIM quote and will provide any material updates to shareholders in due course.

 

 

Transaction after the end of period

 

After the period, Craven House announced a significant transaction with LM Funding America, Inc. (NASDAQ:LMFA) whereby LMFA would acquire IIU, Inc in a transaction which will likely result in Craven House becoming the controlling shareholder in the Nasdaq listed company. The conversion of funds due following the sale in common stock of LMFA requires shareholder approval from LMFA shareholders and is not certain. Should LMFA shareholder approval be granted, Craven House will have another listed subsidiary, with high market liquidity which could serve as a platform for further growth. The likely result will be that Craven House's primary holdings will be two subsidiary listed companies in LMFA and DLC Holdings with the balance of the portfolio comprised of African related assets concentrated in loan portfolios in Angola and South Africa and a trading company focused on the export of consumer and industrial products to Angola.

 

 

Desmond Holdings Ltd

Investment Manager to Craven House Capital Plc

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

 

 

 

Six months ended

 

Year Ended

 

 

 

30 Nov 2018

 

30 Nov 2017

 

31 May 2018

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

$'000

 

$'000

 

$'000

 

 

 

 

 

 

 

 

CONTINUING OPERATIONS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in fair value

 

 

(3,101)

 

42

 

590

 

Other operating income

 

 

 

-

 

 

 

-

 

 

3

 

Administrative expenses

 

 

(339)

 

(591)

 

(988)

 

 

 

 

 

 

 

 

OPERATING LOSS

 

 

(3,440)

 

(549)

 

(395)

 

 

 

 

 

 

 

 

Finance income

2

 

1

 

-

 

-

 

 

 

 

 

 

 

 

LOSS BEFORE INCOME TAX

 

 

 

(3,439)

 

 

(549)

 

 

(395)

 

 

 

 

 

 

 

 

Income tax

3

 

-

 

-

 

-

 

 

 

 

 

 

 

 

LOSS FOR THE PERIOD

 

 

(3,439)

 

(549)

 

(395)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share expressed

 

 

 

 

 

 

 

In cents per share:

 

 

 

 

 

 

 

Basic and diluted

6

 

(137.61)

 

(21.96)

 

(15.80)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF FINANCIAL POSITION

AS AT 30 NOVEMBER 2018

 

 

 

 

 

 

Six months ended

 

Year Ended

 

 

 

30 Nov 2018

 

30 Nov 2017

 

31 May 2018

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

$'000

 

$'000

 

$'000

ASSETS

 

 

 

 

 

 

 

 

NON-CURRENT ASSETS

 

 

 

 

 

 

 

 

Investments at fair value through

 

 

 

 

 

 

 

 

profit or loss

4

 

23,892

 

26,445

 

26,993

 

 

 

 

23,892

 

26,445

 

26,993

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

 

 

Trade and other receivables

 

 

910

 

79

 

924

 

Cash and cash equivalents

 

 

27

 

96

 

213

 

 

 

 

937

 

175

 

1,137

 

TOTAL ASSETS

 

 

24,829

 

26,620

 

28,130

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

 

 

 

SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Called up share capital

5

 

12,594

 

12,594

 

12,594

 

Share premium

 

 

25,128

 

25,128

 

25,128

 

Accumulated deficit

 

 

(16,296)

 

(13,011)

 

(12,857)

 

TOTAL EQUITY

 

 

21,426

 

24,711

 

24,865

 

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Trade and other payables

 

 

2,603

 

1,109

 

2,465

 

NON-CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Loans and borrowings

7

 

800

 

800

 

800

 

TOTAL LIABILITIES

 

 

3,403

 

1,909

 

3,265

 

TOTAL EQUITY AND LIABILITIES

 

 

24,829

 

26,620

 

28,130

 

            

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

 

 

 

Called up share capital

$'000

 

 

Share premium

$'000

 

 

 

Accumulated deficit

$'000

 

 

 

Total

$'000

 

 

 

 

 

 

 

 

 

Balance at 1 June

2017

 

 

12,594

 

 

 

25,128

 

 

 

 

(12,462)

 

 

25,260

 

 

 

 

 

 

 

 

Changes in equity

 

 

 

 

 

 

 

Issue of share capital

-

 

-

 

 

-

-

Transactions with owners

12,594

 

25,128

 

 

(12,462)

25,260

Loss for the period

-

 

-

 

 

(549)

(549)

 

 

 

 

 

 

 

 

Balance at 30 November 2017

 

12,594

 

 

25,128

 

 

 

(13,011)

 

24,711

 

 

 

 

 

 

 

 

Changes in equity

 

 

 

 

 

 

 

Issue of share capital

-

 

-

 

 

-

-

Transactions with owners

12,594

 

25,128

 

 

(12,462)

25,260

Loss for the period

-

 

-

 

 

(395)

(395)

 

 

 

 

 

 

 

 

Balance at 31 May

2018

 

12,594

 

 

25,128

 

 

 

(12,857)

 

24,865

 

 

 

 

 

 

 

 

Changes in equity

 

 

 

 

 

 

 

Issue of share capital

-

 

-

 

 

-

-

Transactions with owners

12,594

 

25,128

 

 

(12,857)

24,865

Loss for the period

-

 

-

 

 

(3,439)

(3,439)

 

 

 

 

 

 

 

 

Balance at 30 November

2018

 

12,594

 

 

25,128

 

 

 

(16,296)

 

21,426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF CASH FLOWS

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

 

 

 

Six months ended

 

Year Ended

 

 

 

30 Nov 2018

 

30 Nov 2017

 

31 May 2018

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

$'000

 

$'000

 

$'000

 

 

 

 

 

 

 

 

Cash flows from operating activities

Loss before income tax

Adjustments for non-cash items

Fair value movement arising on investments

Decrease/(increase) in trade and other receivables

Increase/(decrease) in trade and other payables

Increase in loans and borrowings

 

 

 

(3,439)

 

3,101

14

137

-

 

 

(549)

 

(42)

(4)

(120)

800

 

 

(395)

 

(590)

(849)

1,236

800

Net cash (used)/generated by operating activities

 

 

Cash flows from investing activities

 

 

 

(187)

 

 

85

 

 

202

Acquisition of investments

Proceeds from loan advances repaid

 

 

-

-

 

 

-

-

 

(2,500)

2,500

Net cash used in investing activities

 

 

-

 

-

 

-

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Interest received

 

 

1

 

-

 

-

Net cash from financing activities

 

 

1

 

-

 

-

 

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

 

 

(186)

 

 

85

 

 

202

 

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning

 

 

 

 

 

 

 

of the period

 

 

213

 

11

 

11

 

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the period

 

 

 

27

 

 

96

 

 

213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

         

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

1. ACCOUNTING POLICIES

 

General Information

Craven House Capital Plc is a company incorporated in the United Kingdom under the Companies Act 2006. The address of the registered office is given on the company information page. The Company is listed on the AIM Market of the London Stock Exchange (ticker: CRV).

 

The next annual financial statements of Craven House Capital Plc will be prepared in accordance with applicable International Financial Reporting Standards (IFRS) as adopted for use by the European Union. Accordingly, the interim financial information in this report has been prepared using accounting policies consistent with IFRS. IFRS are subject to amendment and interpretation by the International Accounting Standards Board (IASB) and the International Financial Reporting Interpretations Committee (IFRIC) and there is an on-going process of review and endorsement by the European Commission. The financial information has been prepared on the basis of the IFRS that the directors expect to be applicable as at 31 May 2019.

 

The financial information has been prepared under the historical cost convention, except to the extent varied for fair value adjustments required by accounting standards, and in accordance with applicable International Financial Reporting Standards (IFRS) as adopted for use by the European Union. The principal accounting policies have been applied to all periods presented.

 

This financial information is unaudited and does not constitute statutory financial statements within the meaning of Section 434 of the Companies Act 2006. The financial statements of the Company for the year ended 31 May 2018, which were prepared in accordance with IFRS as adopted for use by the European Union, have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors was unqualified and did not include any statement under Section 498 of the Companies Act 2006.

 

This financial information is presented in United States dollar, rounded to the nearest $'000.

 

The directors do not propose the issuance of a dividend.

 

The interim financial information for the six months ended 30 November 2018 was approved by the directors on 27 February 2019.

 

Going concern

The Company has considerable financial resources. As a consequence, the directors believe that the Company is well placed to manage its business risks successfully. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial information.

 

 

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

 

2. Finance income

 

 

 

 

Six months ended

 

Year Ended

 

 

 

30 Nov 2018

 

30 Nov 2017

 

31 May 2018

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

$'000

 

$'000

 

$'000

 

 

 

 

 

 

 

 

 

Interest receivable

 

 

1

 

-

 

-

 

 

 

 

1

 

-

 

-

 

 

 

 

 

 

 

 

 

 

            

 

3. Taxation

 

No tax charges arose in the period or in comparative periods as a result of losses incurred.

 

 

4.  Investments at fair value through profit or loss

 

 

 

 

 

 

 

 

 

 

Quoted equity investments

$'000

 

 

Unquoted equity investments

$'000

 

 

 

Total

$'000

 

 

 

 

 

 

 

 

 

 

 

At 1 June 2018

 

 

 

 

11,083

 

15,910

26,993

 

Fair value movement

 

 

 

 

 

(4,591)

 

1,490

(3,101)

 

At 30 November 2018

 

 

 

 

6,492

 

17,400

23,892

 

 

 

 

 

 

 

 

 

 

 

 

Following a corporate restructuring undertaken during 2016, investments and loans were transferred from Craven House Capital Plc to its wholly owned subsidiary, Craven Industrial Holdings Plc. The revaluation outlined above therefore represents the valuation applied to the resulting investments held by Craven Industrial Holdings Plc or its subsidiaries as at 30 November 2018 and are described in further detail below.

 

Unquoted investments at 30 November 2018 have been measured on a Level 3 basis as no observable market data was available.

 

Shares in Craven Industrial Holdings Plc are valued at $23,892,006 representing a 100% holding. These have been valued based on the underlying investments within Craven Industrial Holdings Plc as at 30 November 2018. The value of Craven Industrial Holdings Plc is segmented across its principal investments as follows:

 

Shares in DLC Holdings Corp. are valued at $6,491,893 representing 13,676,700 common shares and 43,785,206 preferred shares, which are freely convertible into common shares. Shares in DLC Holdings Corp. are quoted on the Toronto Stock Exchange and were valued at $CAD 0.15 per share as at 30 November 2018.

 

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

4. Investments at fair value through profit or loss (continued)

 

Shares in Qeton Ltd are valued at $1,551,814 representing a 50% holding. This shareholding has been valued on an earnings multiple basis which the directors consider represents the best indication of the fair value at the period end. Qeton Ltd generated EBITDA earnings of €544,873 during the year to 30 November 2018. Shares in Qeton Ltd have been valued at 5x EBITDA earnings. Qeton Ltd has no debt and no material liabilities.

 

Shares in Craven House Angola LDA are valued at $8,903,150 representing a 100% holding. This shareholding has been valued on the net assets of Craven House Angola LDA, which the directors consider represents the best indication of the fair value at the period end. The vast majority of the net assets of Craven House Angola LDA comprise principal and accrued interest on loan facilities made to companies operating in Angola. As of 30 November 2018 all of these loans are performing according to their contractual terms and have therefore been valued at face value plus accrued interest. Craven House Angola LDA has no debt and no material liabilities.

 

Shares in Craven House Capital North America LLC are valued at $4,528,396 representing a 100% holding. This shareholding has been valued on the net assets of Craven House Capital North America LLC, which the directors consider represents the best indication of the fair value at the period end. The vast majority of the assets of Craven House Capital North America LLC comprise shares in IIU, Inc and LM Funding America, Inc. (Nasdaq: LMFA).

 

Shares in Kwikbuild Corporation Ltd are valued at $2,416,753 representing a 97% shareholding. This valuation is based on the value of the net assets of KwikBuild Corporation Ltd, which the directors believe represent the best indication of the fair value at the period end. The vast majority of the net assets of Kwikbuild Corporation Ltd comprise shares in its wholly owned South African subsidiary, which are valued on a net asset basis. The South African subsidiary's assets comprise loan facilities, which are performing according to their contractual terms and real-estate holdings valued on market-comparables. Kwikbuild Corporation Ltd has no debt and no material liabilities.

 

 

 

5. Called up share capital

 

 

Authorised, issued and fully paid share capital as at 30 November 2018 are as follows:

 

Number

Class:

Nominal

30 Nov

 

31 May

 

 

 

Value

2018

 

2018

 

 

 

(Unaudited)

 

(Audited)

 

 

 

$'000

 

$'000

 

 

 

 

 

 

2,499,039

Ordinary

$1.00

2,437

 

2,437

 

 

 

 

 

 

 77,979,412

Deferred

£0.09

9,234

 

9,234

 77,979,412

Deferred

£0.009

923

 

923

 

 

 

12,594

 

12,594

 

 

 

 

 

 

         

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

5. Called up share capital (continued)

 

The aggregate nominal values of the ordinary and deferred shares include exchange differences arising from the translation of shares at historic rates and the translation at the rate prevailing at the date of the change in functional currency.

 

The deferred shares carry no entitlement to receive notice of any general meeting, to attend, speak or vote at such general meeting. Holders are not entitled to receive dividends, and on a winding up of the Company holders of deferred shares are entitled to a return of capital only after the holder of each Ordinary share has received a return of capital together with a payment of £1 million per share. The deferred shares may be cancelled at any time for no consideration by way of a reduction in capital.

 

In the year ended 31 May 2018, the Company extended the time scale of 78,632 fully transferable exercisable warrants which were originally issued in the year ended 31 May 2012. At the date of issue, the warrants could be exercised on or before 30 June 2014, this period has now been extended to 30 June 2020. The warrants are exercisable at a price of $15.00 per share.

 

6. Earnings per share

 

The calculation of basic earnings per share is based on the loss attributable to the equity holders of $3,439,000 divided by the weighted average number of shares in issue during the period of 2,499,038 (six months ended 30 November 2017: loss of $549,000 and 2,499,039 shares; year ended 31 May 2018: loss of $395,000 and 2,499,038 shares).

 

Diluted earnings per share has not been disclosed as the inclusion of the unexercised warrants described in note 5 would be non-dilutive.

 

 

7. Convertible loan note

 

During the year ended 31 May 2018, the Company entered into a $800,000 convertible loan note by way of settlement of a supplier's outstanding fees in the sum of £600,000. The note holder, GEM Investments America, has the right to convert the note at any time prior to maturity.

 

The loan note bears no interest and has a five year term. 

 

 

8. Related party disclosures

 

Craven Industrial Holdings Plc

During the period, the Company made a number of loans to its subsidiary Craven Industrial Holdings Plc. At the period end the outstanding balance of these loans was $41,364 (May 2018: $38,969).

 

Craven House Capital North America LLC

During the period, the Company received a repayment against loans from its subsidiary Craven House Capital North America LLC. At the period end the outstanding balance of these loans was $743,638 (May 2018: $793,629).

 

Craven House Angola LDA

During the period, there was no movement in the $896,781 loan balance outstanding between Company and its subsidiary Craven House Angola LDA.

 

Kwikbuild Corporation Ltd

During the period, the Company received a number of loans from its subsidiary Kwikbuild Corporation Ltd. At the period end the outstanding balance of these loans was $828,545 (May 2018: $785,294).

 

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2018

 

 

 

8. Related party disclosures (continued)

 

7Mobile LDA

During the period, the Company's subsidiary, Qeton Ltd, made sales totalling €320,300 to 7Mobile LDA. 7Mobile LDA shares a director with Craven House Capital Angola LDA. At the period end, amounts receivable by Qeton Ltd from 7Mobile LDA were €1,151,700 (May 2018: $1,485,747).

 

Desmond Holdings Limited

During the period the Company incurred management fees of $120,000 from Desmond Holdings Limited, the Investment Manager of the Company. It also received a loan of $75,000 from Desmond Holdings Limited, $25,000 of which was repaid before the period end. At the period end, included in trade and other payables is an amount of $572,400 due to Desmond Holdings Limited.

 

All amounts owed to related parties are interest free and repayable on demand.

 

9. Events after the reporting period

 

4 January 2019: The Company passed a resolution to extend its capital reduction program to include the cancellation of 155,958,824 deferred shares. This, along with the previously announced resolution to cancel up to $5,000,000 of ordinary common shares, is currently subject to approval by the High Court.

 

17 January 2019: The Company completed the sale of its wholly owned subsidiary, IIU Inc., to LM Funding America Inc. (NASDAQ: LMFA) for a consideration of c. $5.1 million.

 

The Interim Results for the six months ended 30 November 2018 will be available to download from the Company's website at: http://www.cravenhousecapital.com

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR QDLFLKLFZBBF
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.